Crinetics Pharmaceuticals, Inc. (CRNX)
35.56
-0.26
(-0.73%)
USD |
NASDAQ |
Mar 20, 16:00
35.56
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Market Cap : 3.723B for March 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Plus Therapeutics, Inc. | 43.01M |
| Prestige Consumer Healthcare, Inc. | 2.887B |
| Madrigal Pharmaceuticals, Inc. | 10.12B |
| Axsome Therapeutics, Inc. | 8.024B |
| Gossamer Bio, Inc. | 95.98M |
Market Cap Related Metrics
| PS Ratio | 434.57 |
| PEG Ratio | -0.2145 |
| Price to Book Value | 3.753 |
| Price | 35.56 |
| Earnings Yield | -13.90% |
| PEGY Ratio | -0.2145 |